X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6288) 6288
Book Chapter (50) 50
Dissertation (6) 6
Publication (4) 4
Book / eBook (3) 3
Streaming Video (3) 3
Web Resource (3) 3
Conference Proceeding (2) 2
Government Document (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
maximum tolerated dose (5887) 5887
humans (5508) 5508
female (4494) 4494
male (4279) 4279
middle aged (3772) 3772
oncology (3692) 3692
aged (3509) 3509
adult (3210) 3210
dose-response relationship, drug (2368) 2368
treatment outcome (2152) 2152
drug administration schedule (1568) 1568
cancer (1564) 1564
antineoplastic combined chemotherapy protocols - therapeutic use (1503) 1503
chemotherapy (1324) 1324
neoplasms - drug therapy (1279) 1279
antineoplastic combined chemotherapy protocols - adverse effects (1092) 1092
pharmacology & pharmacy (1069) 1069
aged, 80 and over (997) 997
animals (864) 864
neoplasm staging (847) 847
clinical trials (823) 823
toxicity (787) 787
pharmacokinetics (781) 781
follow-up studies (777) 777
antineoplastic agents - administration & dosage (772) 772
antineoplastic combined chemotherapy protocols - administration & dosage (744) 744
therapy (724) 724
care and treatment (707) 707
research (706) 706
medicine & public health (700) 700
prognosis (695) 695
antineoplastic agents - adverse effects (675) 675
survival rate (663) 663
trial (638) 638
infusions, intravenous (610) 610
tumors (586) 586
administration, oral (583) 583
pharmacology/toxicology (565) 565
phase i (561) 561
risk assessment (561) 561
antineoplastic agents - therapeutic use (543) 543
survival analysis (543) 543
cisplatin (542) 542
deoxycytidine - analogs & derivatives (540) 540
adolescent (533) 533
antineoplastic agents - pharmacokinetics (532) 532
lung neoplasms - drug therapy (501) 501
drug therapy (485) 485
mice (483) 483
deoxycytidine - administration & dosage (481) 481
combination (474) 474
young adult (474) 474
paclitaxel (465) 465
disease-free survival (455) 455
radiotherapy (438) 438
neoplasms - pathology (416) 416
analysis (403) 403
time factors (391) 391
patients (389) 389
safety (385) 385
antineoplastic agents (381) 381
paclitaxel - administration & dosage (380) 380
carcinoma (379) 379
solid tumors (379) 379
hematology (376) 376
dosage and administration (374) 374
gemcitabine (373) 373
cisplatin - administration & dosage (368) 368
carcinoma, non-small-cell lung - drug therapy (366) 366
hematology, oncology and palliative medicine (360) 360
pharmacology (355) 355
efficacy (354) 354
cancer research (351) 351
antimitotic agents (350) 350
antineoplastic combined chemotherapy protocols - pharmacokinetics (348) 348
fluorouracil - administration & dosage (340) 340
child (333) 333
survival (328) 328
neoplasm recurrence, local - drug therapy (325) 325
camptothecin - analogs & derivatives (320) 320
cohort studies (318) 318
docetaxel (314) 314
expression (310) 310
medical research (310) 310
metastasis (307) 307
combined modality therapy (306) 306
lung neoplasms - pathology (306) 306
prospective studies (301) 301
area under curve (300) 300
adenocarcinoma - drug therapy (296) 296
radiology, nuclear medicine & medical imaging (290) 290
camptothecin - administration & dosage (281) 281
breast neoplasms - drug therapy (280) 280
cell lung-cancer (270) 270
rats (267) 267
carboplatin (265) 265
oncology, experimental (263) 263
fluorouracil (260) 260
taxoids - administration & dosage (259) 259
irinotecan (257) 257
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6268) 6268
Japanese (58) 58
French (18) 18
Russian (18) 18
Chinese (15) 15
German (15) 15
Korean (9) 9
Spanish (4) 4
Polish (3) 3
Italian (2) 2
Portuguese (2) 2
Dutch (1) 1
Finnish (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Advances in Therapy, ISSN 0741-238X, 5/2019, Volume 36, Issue 5, pp. 1150 - 1163
Journal Article
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2009, Volume 27, Issue 33, pp. 5538 - 5546
Purpose Cross-talk between human epidermal growth factor receptors and hormone receptor pathways may cause endocrine resistance in breast cancer. This trial... 
EFFICACY | ONCOLOGY | RANDOMIZED PHASE-II | TAMOXIFEN RESISTANCE | GROWTH | MCF-7 CELLS | COMBINATION | INHIBITOR | EXPRESSION | ESTROGEN-RECEPTOR | PLUS | Triazoles - administration & dosage | Triazoles - adverse effects | Postmenopause - drug effects | Receptors, Estrogen - metabolism | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma - mortality | Receptors, Progesterone - genetics | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Dose-Response Relationship, Drug | Nitriles - administration & dosage | Antineoplastic Agents, Hormonal - adverse effects | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Carcinoma - pathology | Carcinoma - secondary | Carcinoma - drug therapy | Receptors, Estrogen - genetics | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Biomarkers, Tumor - analysis | Antineoplastic Agents, Hormonal - administration & dosage | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Maximum Tolerated Dose | Breast Neoplasms - pathology | Quinazolines - adverse effects | Survival Analysis | Breast Neoplasms - mortality | Aged | Biomarkers, Tumor - genetics | Carcinoma - metabolism | Neoplasm Staging | Nitriles - adverse effects | Index Medicus | Carcinoma | Quinazolines | Breast Neoplasms | Life Sciences | Immunology | Triazoles | Postmenopause | Nitriles | Antineoplastic Agents, Hormonal | Tumor Markers, Biological | Receptors, Estrogen | Neoplasm Invasiveness | Antineoplastic Combined Chemotherapy Protocols | Receptor, erbB-2 | Receptors, Progesterone | Kaplan-Meiers Estimate
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1287 - 1288
Journal Article
Journal Article
British journal of clinical pharmacology, ISSN 1365-2125, 2019, Volume 85, Issue 10, pp. 2213 - 2217
.... However, clinicians often prescribe up to maximum tolerated dose (MTD), especially when treating acute and more severe disease, without evidence to show that MTD is more likely to improve outcomes... 
clinical pharmacology | maximum tolerated dose | dosing outcomes | effective dose 50 | Therapeutics | Homeopathy | Materia medica and therapeutics
Journal Article